|
humans |
5 |
|
abdominal aortic aneurysm |
4 |
|
pathogenesis |
4 |
|
aneurysm, dissecting - enzymology - etiology |
3 |
|
aortic aneurysm - enzymology - etiology |
3 |
|
controls |
3 |
|
low-density lipoprotein receptor-related protein-1 |
3 |
|
metalloproteases - physiology |
3 |
|
abdominal aortic aneurysms |
2 |
|
adult |
2 |
|
aged |
2 |
|
aged, 80 and over |
2 |
|
annexin a1 |
2 |
|
aorta - metabolism |
2 |
|
aorta - metabolism - physiology |
2 |
|
aorta, abdominal - cytology - metabolism |
2 |
|
aortic aneurysm, abdominal - etiology - metabolism - physiopathology |
2 |
|
aortic aneurysm, abdominal - etiology - pathology - physiopathology |
2 |
|
aortic aneurysm, abdominal - metabolism |
2 |
|
aortic aneurysm, abdominal - metabolism - radiography - surgery |
2 |
|
aortic rupture - etiology - pathology - physiopathology |
2 |
|
aortic rupture - metabolism - radiography - surgery |
2 |
|
atherosclerosis |
2 |
|
atherosclerosis - blood - complications - mortality |
2 |
|
biological markers - blood |
2 |
|
blotting, western |
2 |
|
c. pneumoniae |
2 |
|
carotid |
2 |
|
carotid plaques |
2 |
|
collagen type 1 alpha 1 |
2 |
|
collagen type i - metabolism |
2 |
|
contraception |
2 |
|
cyclooxygenase |
2 |
|
cyclooxygenase 2 - metabolism |
2 |
|
cystic fibrosis transmembrane conductance regulator |
2 |
|
dinoprostone - secretion |
2 |
|
dna |
2 |
|
elastin - metabolism |
2 |
|
epididymis |
2 |
|
extracellular matrix |
2 |
|
extracellular matrix - physiology |
2 |
|
female |
2 |
|
fibrinogen - analysis |
2 |
|
gene expression |
2 |
|
hong kong |
2 |
|
human vascular smooth muscle cells |
2 |
|
immunohistochemistry |
2 |
|
immunohistochemistry - methods |
2 |
|
imt |
2 |
|
inflammation mediators - metabolism |
2 |
|
integrin |
2 |
|
integrin alpha5beta1 - genetics - metabolism |
2 |
|
integrin alpha5beta1 - metabolism |
2 |
|
interleukin-6 |
2 |
|
interleukin-6 - secretion |
2 |
|
macrophages - pathology |
2 |
|
male |
2 |
|
media |
2 |
|
microrna-1260 |
2 |
|
middle aged |
2 |
|
muscle, smooth - cytology |
2 |
|
muscle, smooth, vascular - physiology |
2 |
|
pcr-eia |
2 |
|
peripheral vascular diseases - blood - etiology - mortality |
2 |
|
plaque characteristics |
2 |
|
prostaglandin e2 |
2 |
|
prostaglandins - metabolism |
2 |
|
receptors, lysosphingolipid - metabolism |
2 |
|
risk factors |
2 |
|
rna, messenger - analysis |
2 |
|
rupture |
2 |
|
ruptured abdominal aortic aneurysms |
2 |
|
secretion |
2 |
|
survival analysis |
2 |
|
thromboxane a2 |
2 |
|
thromboxane a2 - secretion |
2 |
|
thromboxane b2 - secretion |
2 |
|
tissue culture techniques |
2 |
|
animals |
1 |
|
anions - metabolism |
1 |
|
apoptosis |
1 |
|
apoptosis - physiology |
1 |
|
bradykinin - analogs & derivatives - metabolism - pharmacology |
1 |
|
bradykinin - pharmacology |
1 |
|
calcium - metabolism |
1 |
|
calcium signaling - drug effects - physiology |
1 |
|
cells, cultured |
1 |
|
cyclic amp - metabolism |
1 |
|
cyclic amp - pharmacology |
1 |
|
cyclooxygenase 1 |
1 |
|
cyclooxygenase 2 |
1 |
|
cyclooxygenase 2 inhibitors |
1 |
|
cyclooxygenase inhibitors - pharmacology |
1 |
|
dinoprostone - metabolism - secretion |
1 |
|
dinoprostone - pharmacology |
1 |
|
dna fragmentation |
1 |
|
dose-response relationship, drug |
1 |
|
electrophoresis, capillary |
1 |
|
enzyme inhibitors - pharmacology |
1 |
|
epididymis - cytology |
1 |
|
epididymis - drug effects - enzymology - secretion |
1 |
|
epididymis - enzymology |
1 |
|
epithelial cells - drug effects - enzymology - secretion |
1 |
|
epithelium - enzymology |
1 |
|
fluorescence |
1 |
|
forskolin - pharmacology |
1 |
|
gene expression regulation, enzymologic - drug effects |
1 |
|
in situ nick-end labeling |
1 |
|
ion channels - antagonists & inhibitors - metabolism |
1 |
|
isoenzymes - drug effects - metabolism |
1 |
|
isoenzymes - genetics |
1 |
|
isoenzymes - physiology |
1 |
|
kallidin - pharmacology |
1 |
|
lasers |
1 |
|
membrane proteins |
1 |
|
naphthalenes - pharmacology |
1 |
|
nitrobenzenes |
1 |
|
orchiectomy |
1 |
|
organophosphorus compounds - pharmacology |
1 |
|
prostaglandin d2 - physiology |
1 |
|
prostaglandin-endoperoxide synthases - drug effects - metabolism |
1 |
|
prostaglandin-endoperoxide synthases - genetics |
1 |
|
prostaglandin-endoperoxide synthases - physiology |
1 |
|
prostaglandins |
1 |
|
rats |
1 |
|
rats, sprague-dawley |
1 |
|
receptors, bradykinin - antagonists & inhibitors - metabolism |
1 |
|
reverse transcriptase polymerase chain reaction |
1 |
|
signal transduction |
1 |
|
signal transduction - drug effects - physiology |
1 |
|
sulfonamides |
1 |
|
testosterone |
1 |
|
testosterone - pharmacology |
1 |
|
vasodilator agents - pharmacology |
1 |
